{"id":"https://openalex.org/W3089172788","doi":"https://doi.org/10.1016/j.annonc.2020.08.664","title":"550P Preclinical characterization of CPL304110 as a potential selective inhibitor of fibroblast growth factors 1/2/3 in solid cancers","display_name":"550P Preclinical characterization of CPL304110 as a potential selective inhibitor of fibroblast growth factors 1/2/3 in solid cancers","publication_year":2020,"publication_date":"2020-09-01","ids":{"openalex":"https://openalex.org/W3089172788","doi":"https://doi.org/10.1016/j.annonc.2020.08.664","mag":"3089172788"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2020.08.664","doi":"https://doi.org/10.1016/j.annonc.2020.08.664","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2020.08.664","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.annonc.2020.08.664","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010689580","display_name":"Delfina Popiel","orcid":"https://orcid.org/0000-0002-6820-0338","observed_orcids":["https://orcid.org/0000-0002-6820-0338"]},"institutions":[{"id":"https://openalex.org/I4210096162","display_name":"Celon Pharma (Poland)","ror":"https://ror.org/00y35qw13","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210096162"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"D. Popiel","raw_affiliation_strings":["Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland","institution_ids":["https://openalex.org/I4210096162"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110447370","display_name":"Agata Miko\u0142ajczyk","orcid":"https://orcid.org/0009-0009-9279-3514","observed_orcids":["https://orcid.org/0009-0009-9279-3514"]},"institutions":[{"id":"https://openalex.org/I4210096162","display_name":"Celon Pharma (Poland)","ror":"https://ror.org/00y35qw13","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210096162"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"A. Miko\u0142ajczyk","raw_affiliation_strings":["Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland","institution_ids":["https://openalex.org/I4210096162"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045102648","display_name":"Monika Skupi\u0144ska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096162","display_name":"Celon Pharma (Poland)","ror":"https://ror.org/00y35qw13","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210096162"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"M.M. Skupinska","raw_affiliation_strings":["Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland","institution_ids":["https://openalex.org/I4210096162"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027018035","display_name":"Joanna Hucz\u2010Kalitowska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096162","display_name":"Celon Pharma (Poland)","ror":"https://ror.org/00y35qw13","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210096162"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"J. Hucz-Kalitowska","raw_affiliation_strings":["Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland","institution_ids":["https://openalex.org/I4210096162"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030930495","display_name":"Paulina Seweryna Sta\u0144czak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096162","display_name":"Celon Pharma (Poland)","ror":"https://ror.org/00y35qw13","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210096162"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"P. Sta\u0144czak","raw_affiliation_strings":["Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland","institution_ids":["https://openalex.org/I4210096162"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051069535","display_name":"N. Piotrkowska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096162","display_name":"Celon Pharma (Poland)","ror":"https://ror.org/00y35qw13","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210096162"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"N. Piotrkowska","raw_affiliation_strings":["Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland","institution_ids":["https://openalex.org/I4210096162"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001779027","display_name":"Abdellah Yamani","orcid":"https://orcid.org/0009-0006-9516-9387","observed_orcids":["https://orcid.org/0009-0006-9516-9387"]},"institutions":[{"id":"https://openalex.org/I4210096162","display_name":"Celon Pharma (Poland)","ror":"https://ror.org/00y35qw13","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210096162"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"A. Yamani","raw_affiliation_strings":["Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland","institution_ids":["https://openalex.org/I4210096162"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113859891","display_name":"KRZYSZTOF K. DUBIEL","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096162","display_name":"Celon Pharma (Poland)","ror":"https://ror.org/00y35qw13","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210096162"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"K. Dubiel","raw_affiliation_strings":["Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland","institution_ids":["https://openalex.org/I4210096162"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018257810","display_name":"Jerzy Pieczykolan","orcid":"https://orcid.org/0000-0002-5887-0952","observed_orcids":["https://orcid.org/0000-0002-5887-0952"]},"institutions":[{"id":"https://openalex.org/I4210096162","display_name":"Celon Pharma (Poland)","ror":"https://ror.org/00y35qw13","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210096162"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"J. Pieczykolan","raw_affiliation_strings":["Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland","institution_ids":["https://openalex.org/I4210096162"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074594600","display_name":"Maciej Wieczorek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096162","display_name":"Celon Pharma (Poland)","ror":"https://ror.org/00y35qw13","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210096162"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"M. Wieczorek","raw_affiliation_strings":["Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland","institution_ids":["https://openalex.org/I4210096162"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043905816","display_name":"Aleksandra M. Stanczak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096162","display_name":"Celon Pharma (Poland)","ror":"https://ror.org/00y35qw13","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210096162"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"A. Stanczak","raw_affiliation_strings":["Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Centre, Celon Pharma, Kie\u0142pin, Poland","institution_ids":["https://openalex.org/I4210096162"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210096162"],"apc_list":{"value":2528,"currency":"USD","value_usd":2528},"apc_paid":null,"fwci":0.1429,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.36847901,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"31","issue":null,"first_page":"S478","last_page":"S478"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fibroblast-growth-factor-receptor","display_name":"fibroblast growth factor receptor","score":0.8820000290870667},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinase-inhibitors","display_name":"receptor tyrosine kinase inhibitors","score":0.746999979019165},{"id":"https://openalex.org/keywords/kinase-inhibitor-selectivity","display_name":"kinase selectivity","score":0.7440000176429749},{"id":"https://openalex.org/keywords/fgfr2","display_name":"FGFR2","score":0.5090000033378601},{"id":"https://openalex.org/keywords/fgfr1","display_name":"FGFR1","score":0.7770000100135803},{"id":"https://openalex.org/keywords/fgfr3","display_name":"FGFR3","score":0.9639999866485596},{"id":"https://openalex.org/keywords/antitumour-activity","display_name":"antitumour activity","score":0.6190000176429749},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.8679999709129333}],"concepts":[{"id":"https://openalex.org/C82867764","wikidata":"https://www.wikidata.org/wiki/Q24780051","display_name":"Fibroblast growth factor receptor","level":4,"score":0.8257725238800049},{"id":"https://openalex.org/C49418065","wikidata":"https://www.wikidata.org/wiki/Q14914258","display_name":"Fibroblast growth factor receptor 1","level":4,"score":0.8002651929855347},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6724501848220825},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.5958760976791382},{"id":"https://openalex.org/C74373430","wikidata":"https://www.wikidata.org/wiki/Q24727126","display_name":"Fibroblast growth factor","level":3,"score":0.532173216342926},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.5273697376251221},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.513191282749176},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4853857755661011},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4820478856563568},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4468916356563568},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.43022334575653076},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4281042814254761},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32621169090270996},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3165060579776764},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2742443084716797},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25052276253700256},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20660454034805298}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2020.08.664","doi":"https://doi.org/10.1016/j.annonc.2020.08.664","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2020.08.664","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2020.08.664","doi":"https://doi.org/10.1016/j.annonc.2020.08.664","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2020.08.664","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4390824083","https://openalex.org/W1969012061","https://openalex.org/W2138272238","https://openalex.org/W1446747868","https://openalex.org/W1438994669","https://openalex.org/W4380029343","https://openalex.org/W1765107706","https://openalex.org/W2142702787","https://openalex.org/W4409625284","https://openalex.org/W3097439385"],"abstract_inverted_index":null,"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-10-01T00:00:00"}